Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as $12.28 and last traded at $12.18, with a volume of 379832 shares. The stock had previously closed at $10.87. Analyst Upgrades and Downgrades NKTX has been the subject of several […]
Pacira Appoints Frank D. Lee as Chief Executive Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Penny stocks are risky but have the potential to triple initial investments. While risk-averse investors might associate penny stocks with gambling, conducting proper research and noting market sentiment regarding such low-value stocks can help traders identify strategic investment opportunities. But pump-and-dump schemes where market-makers artificially inflate the price of penny stocks through advertising are fairly common. While the promoters often end up cold calling clients or sending email
SAB Biotherapeutics (NASDAQ: SABS), gained 28% today as the clinical-stage biopharmaceutical company pioneering a novel immunotherapy platform received approval from the Australian Human Research Ethics Committee (HREC) to initiate the first-in-human Phase 1 clinical trial of SAB-142. Type 1 Diabetes Asset: SAB-142 is a fully-human anti-thymocyte immunoglobulin designed to modify the progression of type 1
Nkarta (NKTX) Receives FDA Clearance of IND Application for NKX019 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.